geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Anticoagulant treatment as a risk factor for primary intracerebral haemorrhage


, : Anticoagulant treatment as a risk factor for primary intracerebral haemorrhage. Journal of Neurology, Neurosurgery, and Psychiatry 55(12): 1121-1124

Forty one (14.2%) of 288 patients with primary intracerebral haemorrhage occurring between September 1985 and December 1989 in Central Finland were on anticoagulant treatment at the onset of symptoms. In a sample of 29,000 subjects from the same population the prevalence of anticoagulant treatment was 1.6% in those aged 40 years or older. The estimated age adjusted odds ratio of being on anticoagulant treatment at the time of primary intracerebral haemorrhage was 6.7 (95% CI from 4.5 to 9.9). The risk was highest during the first year of anticoagulation. Overtreatment (thrombotest value < 5%) was slightly more common among the patients. The haematoma volumes measured from the CT scans were similar in patients on anticoagulant treatment and those not anticoagulated. The case fatality rate during the first week and the mortality during follow up of 32 months were slightly higher, and the functional outcome slightly worse in the anticoagulated group.

US$19.90

PMID: 1479389

DOI: 10.1136/jnnp.55.12.1121


Other references

Ford, S.; Middleton, J., 2014: Lack of nurses at the top leads NMC to set up advisory panel. Nursing Times 110(29): 3-3

Pinto M.; Gill T.J.IIi; Kunz H.W., 1983: Prolongation of skin graft survival across different genetic barriers in rats with cyclosporin and its potentiation by bordetella pertussis vaccine. Skin allografting was performed in rats treated with cyclosporine using strain combinations that differed across the RT1.A (class I) or RT1.B (class II) loci of the major histocompatibility complex (MHC) or across non-MHC loci. Injection of cyclos...

Huang FuPing; Liang YueRong; L.J.anLiang; Chen RongBing; Mamati, G.E.; Sun QingLei, 2004: Evaluation of genetic diversity in Oolong tea germplasms by AFLP fingerprinting. The genetic diversity in 45 Oolong tea germplasms collected from Fujian, Guangdong, China, and Taiwan was evaluated by AFLP fingerprinting based on silver staining technique using 5 primer combinations. The 5 primer combinations generated 208 poly...

Stemmerik Lars, 1997: Mid-Carboniferous-Permian evolution of the North Atlantic margin of Pangaea. Gaea Heidelbergensis 3: 320

Lepine, P.R., 1950: Ornithosis; etiology, symptomatology and diagnosis. La Semaine des Hopitaux 26(65): 3376-3385

Booth, D.M.; Parker, R.M., 1987: Bonding: a critical component for learning, performing, and staying. Ad Nurse 2(6): 21-23

Chubb, C.; Ewing, L.; Irby, D.; Desjardins, C., 1978: Testicular maturation in the rabbit: secretion of testosterone, dihydrotestosterone, 5 alpha -androstan-3 alpha ,17 beta -diol and 5 alpha -androstan-3 beta ,17 beta -diol by perfused rabbit testes-epididymides and spermatogenesis. From the results of in vitro, testis-perfusion experiments it appears that testosterone is the chief androgen elaborated throughout prepuberal and postpuberal testicular development, a finding which contrasts with the predominant formation of 5 al...

Corwin, H.L., 2004: Erythropoietin in the critically ill - is it more than just blood?. Erythropoietin (EPO) has been in clinical use for the treatment of anemia for over 15 years. Recently it has been demonstrated that EPO has actions other than stimulating the bone marrow. It has been suggested that due to its tissue protecting eff...

Ogawa, Y., 1981: Studies on oxalate in urolithiasis. III. Effect of xylitol infusion on plasma and urinary oxalate. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 72(12): 1553-1558

Eapen, M.; Wang, T.; Veys, P.A.; Boelens, J.J.; St Martin, A.; Spellman, S.; Bonfim, C.Sales.; Brady, C.; Cant, A.J.; Dalle, J-Hugues.; Davies, S.M.; Freeman, J.; Hsu, K.C.; Fleischhauer, K.; Kenzey, C.; Kurtzberg, J.; Michel, G.; Orchard, P.J.; Paviglianiti, A.; Rocha, V.; Veneris, M.R.; Volt, F.; Wynn, R.; Lee, S.J.; Horowitz, M.M.; Gluckman, E.; Ruggeri, A., 2017: Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis. The standard for selecting unrelated umbilical cord blood units for transplantation for non-malignant diseases relies on antigen-level (lower resolution) HLA typing for HLA-A and HLA-B, and allele-level for HLA-DRB1. We aimed to study the effects...